Richard Glynne

Richard Glynne

Algemeen Directeur bij
Belharra Therapeutics, Inc.
Health Technology
Commercial Services
Finance

Profiel

Dr. Richard Glynne is a Chief Executive Officer at Belharra Therapeutics, Inc., a CSO at Inception Sciences, Inc. and a Venture Partner at Versant Venture Management LLC.
Dr. Glynne was previously employed as an Associate by NewCo /Ca/, an Executive Director by Novartis Institutes for Biomedical Research, Inc., an Executive Director of Genetics by Novartis AG, a VP Genetics by Phenomix Corp., and a Director Genomics by EOS Biotechnology, Inc. He received his doctorate degree from Imperial Cancer Research Fund Trading Ltd..

Actieve functies van Richard Glynne

BedrijvenFunctieBegin
Private Equity Investor 01-01-2018
Corporate Officer/Principal 01-11-2018
Algemeen Directeur 01-01-2025

Eerdere bekende functies van Richard Glynne

BedrijvenFunctieEinde
Corporate Officer/Principal 01-11-2018
Private Equity Investor 01-01-2018
NOVARTIS AG Private Equity Investor 01-01-2015
Private Equity Investor 01-01-2004
Corporate Officer/Principal 01-01-2002
Ervaring van Richard Glynne in detail bekijken

Opleiding van Richard Glynne

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

76

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Consumer Services

Health Technology

Distribution Services

Commercial Services

  1. Beurs
  2. Insiders
  3. Richard Glynne